These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 9550750)

  • 1. [Cystic fibrosis: special value of treatment at a center].
    Mannes GP; Heijerman HG
    Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2001-4. PubMed ID: 9550750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of hospital and home intravenous antibiotic therapy in adults with cystic fibrosis.
    Esmond G; Butler M; McCormack AM
    J Clin Nurs; 2006 Jan; 15(1):52-60. PubMed ID: 16390524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of high-dose ibuprofen in a pediatric cystic fibrosis center.
    Fennell PB; Quante J; Wilson K; Boyle M; Strunk R; Ferkol T
    J Cyst Fibros; 2007 Apr; 6(2):153-8. PubMed ID: 16844429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in care of adult CF patients--the specialist cystic fibrosis team.
    Goździk J; Majka-Sumner L; Cofta S; Nowicka A; Piorunek T; Batura-Gabryel H
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():42-5. PubMed ID: 16119624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A cystic fibrosis center in a general hospital: the Versailles experience].
    Foucaud P; Bonnel A; Ajzenman C; Le Monnier A; Le Jalle S; Borel B
    Arch Pediatr; 2010 Jun; 17(6):727-8. PubMed ID: 20654862
    [No Abstract]   [Full Text] [Related]  

  • 6. Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?
    Burkhardt O; Lehmann C; Madabushi R; Kumar V; Derendorf H; Welte T
    J Antimicrob Chemother; 2006 Oct; 58(4):822-9. PubMed ID: 16885180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structured care in an ISO certified centre for patients with cystic fibrosis and their families].
    Ellemunter H; Eder J; Steinkamp G
    Pneumologie; 2011 Oct; 65(10):615-23. PubMed ID: 21761387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary nocardiosis in cystic fibrosis.
    Thorn ST; Brown MA; Yanes JJ; Sherrill DL; Pugmire J; Anderson KA; Klotz SA
    J Cyst Fibros; 2009 Sep; 8(5):316-20. PubMed ID: 19683479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting energy expenditure in young patients with cystic fibrosis receiving antibiotic therapy for acute respiratory exacerbations.
    Castro M; Diamanti A; Gambarara M; Bella S; Lucidi V; Papadatou B; Ferretti F; Rosati P; Rupi E
    Clin Nutr; 2002 Apr; 21(2):141-4. PubMed ID: 12056786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with oral N-acetyl-cysteine treatment in children suffering from cystic fibrosis (author's transl)].
    Dietzsch HJ; Berger G; Gottschalk B; Leupold W; Mittenzwey KW; Rupprecht E; Wunderlich P
    Z Erkr Atmungsorgane; 1980; 155(1):109-13. PubMed ID: 7210734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dornase alfa in the treatment of cystic fibrosis in Europe: a report from the Epidemiologic Registry of Cystic Fibrosis.
    Hodson ME; McKenzie S; Harms HK; Koch C; Mastella G; Navarro J; Strandvik B;
    Pediatr Pulmonol; 2003 Nov; 36(5):427-32. PubMed ID: 14520726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study.
    van Ewijk BE; van der Zalm MM; Wolfs TF; Fleer A; Kimpen JL; Wilbrink B; van der Ent CK
    Pediatrics; 2008 Dec; 122(6):1171-6. PubMed ID: 19047230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein.
    Grey V; Mohammed SR; Smountas AA; Bahlool R; Lands LC
    J Cyst Fibros; 2003 Dec; 2(4):195-8. PubMed ID: 15463873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cystic fibrosis--a disease of adolescents and adults?].
    Vávrová V; Zemková D; Bartosová J; Zapletal A; Smolíková L; Krebsová A; Koudová M; Macek M
    Cas Lek Cesk; 1999 Nov; 138(21):654-9. PubMed ID: 10746022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transition programs in cystic fibrosis centers: perceptions of team members.
    Flume PA; Taylor LA; Anderson DL; Gray S; Turner D
    Pediatr Pulmonol; 2004 Jan; 37(1):4-7. PubMed ID: 14679482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality improvement in your CF centre: taking care of care.
    Tiddens HA
    J Cyst Fibros; 2009 Jun; 8 Suppl 1():S2-5. PubMed ID: 19460683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results concerning the state of children with mucoviscidosis treated in a specialized center. (4 years of experience at the Heliomarin Centre in roscoff)].
    Jehanne M; Guivarch J; Hennequet A
    Ann Pediatr (Paris); 1972 Feb; 19(2):153-61. PubMed ID: 5053189
    [No Abstract]   [Full Text] [Related]  

  • 20. Improving care at cystic fibrosis centers through quality improvement.
    Kraynack NC; McBride JT
    Semin Respir Crit Care Med; 2009 Oct; 30(5):547-58. PubMed ID: 19760542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.